Respiratory

Latest News

Previous randomized controlled trials have established mepolizumab’s efficacy, but the new study aimed to analyze its performance in a diverse, real-world patient population. | Image credit: luchschenF - stock.adobe.com
Real-World Study Reinforces Mepolizumab's Effectiveness in Severe Eosinophilic Asthma

September 12th 2025

Mepolizumab showed significant real-world improvements in asthma outcomes, reducing exacerbations and corticosteroid use in severe eosinophilic asthma.

Man holding a cigarette | Image Credit: Nopphon - stock.adobe.com
Rurality, Long Travel Times Limit Access to Tobacco Treatment for Patients With COPD Who Smoke

August 30th 2025

Zopapogene imadenovec, a non-replicating adenoviral vector-based immunotherapy, expresses a fusion antigen made up of selected regions of human papillomavirus (HPV) types 6 and 11 proteins. | Image Credit: aznan - stock.adobe.com
FDA Approves Zopapogene Imadenovec for Recurrent Respiratory Papillomatosis

August 19th 2025

The results showed a significant improvement in patient-reported symptoms at the 12-month follow-up. | Image credit: doucefleur - stock.adobe.com
Biologics Relieve Ear-Related Symptoms Linked With Asthma, CRwNP

August 16th 2025

Obstructive sleep apnea syndrome. | Image Credit:  Chinnapong -  stock.adobe.com
Multidisciplinary Approaches to Pediatric Obstructive Sleep Apnea: A Review of Respiratory Therapies

August 13th 2025

More News

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo